Evidence & regulatory context
- Mechanism
- Not recorded
- Target
- Not recorded
- Injury models
- Haemorrhage/shock
- Reported indication
- Not recorded
- First approval
- Not recorded
- Development stage
- Not recorded
- ChEMBL record
- Not recorded
- ChEMBL max phase
- Not recorded
- Synonyms
- Not recorded
- Note
- Not recorded
Clinical trials 0
0 linked trials carry an injury-indication flag. These flags support record-level exploration and sit alongside the stringent aggregate counts described in Methods.
No linked human trial in this dataset.
Preclinical evidence 1
1 studies reported at therapy level; 1 evidence entries itemised.
RatHaemorrhage/shockControlledSprague-DawleyMaleHigh molecular weight polyethylene glycol by injection into the duodenum; doxantrazole and ketotifen intraperitoneal; pancreatic duct cannulation and exteriorisation at laparotomyHigh molecular weight polyethylene glycol 5% solution at 30…Polyethylene glycol and pancreatic duct exteriorisation performed during the la…
Model: Trauma-haemorrhagic shock: 3 cm midline laparotomy with 15 min bowel evisceration, blood withdrawal at 1 mL/min to mean arterial pressure 30 to 35 mmHg maintained for 90 min, then resuscitation by reinfusion of shed blood; assessment 3 h after resuscitation
Pancreatic duct exteriorisation abrogated trauma-haemorrhagic shock-induced gut barrier loss, villous injury and mucus loss and partially limited mucus oxidation and nitration. Intraduodenal high molecular weight polyethylene glycol prevented increased gut permeability, villous injury, bacterial tr…
Extraction: extract · Subtype source: llm · Supplied extraction confidence: 0.88. Machine-extracted fields require source verification.